BENIGN INTRACRANIAL
HYPERTENSION
Pembimbing:
dr. Usman Gumanti Rangkuti, Sp.S
2
Wanita dan obesitas (90%)
3
PATOFISIOLOGI
4
ETIOLOGI MANIFESTASI KLINIS FAKTOR RESIKO
Obesitas
Intoksikasi vitamin A
Tetracyclin treatment
Withdrawal corticosteroid
Menstrual irregularities
Trombosis sinus cavernosus
5
ETIOLOGI MANIFESTASI KLINIS FAKTOR RESIKO
6
BAB I BAB II BAB III BAB IV BAB V
ETIOLOGI MANIFESTASI KLINIS DIAGNOSIS
Manifestasi Klinis
Lumbal Pungsi
CT Scan kepala / MRI
7
BAB I BAB II BAB III BAB IV BAB V
8
TERAPI
Prinsip terapi :
Menjaga fungsi visual
Menurunkan gejala nyeri kepala yang difuse
Weight Loss
Farmakoterapi :
- Acetazolamide
- Topiramate
- Obat lainnya :
Furosemide -> Kontraindikasi acetazolamide
Octreotid -> somatostatis analog, bekerja dengan menghambat sekresi
Growth Hormones
Non farmakoterapi
- Lumbal pungsi
- Optic nerve sheath fenestration (ONSF)
- CSF diversion surgey
- Tranverse sinus stenting 9
DAFTAR PUSTAKA
1. Snell, RS. Anatomi Klinik untuk Mahasiswa Kedokteran. Edisi 6. Jakarta : Penerbit Buku Kedokteran EGC. 2006.
hal. 324-7.
2. Brazis, P. W., M.D. (2004). Pseudotumor cerebri. Current Neurology and Neuroscience Reports, 4(2), 111-6.
doi:http://dx.doi.org/10.1007/s11910-004-0024-6.
3. Friedman DI, Jacobson DM. (2008). Diagnostic criteria for idiopathic intracranial hypertension. Neurology,
2002;59;1492-1495.
4. Young WB, Silberstein SD. Headache and Facial Pain. Dalam: Goetz CG, editor. Textbook of clinical neurology,
edisi ketiga. Philadelphia:Saunders Elsevier, 2007. hal. 1256-8.
5. Wall, M. (2008). Idiopathic intracranial hypertension (pseudotumor cerebri). Current Neurology and
Neuroscience Reports, 8(2), 87-93.
6. Galgano, M. A., & Deshaies, E. M. (2013). An update on the management of pseudotumor cerebri. Clinical
Neurology and Neurosurgery, 115(3), 252-9.
10
TERIMA KASIH
11